Product Information
JOURNAVX 50 MG TABLET is a brand product labeled by Vertex Pharmaceuticals Incorporated, priced at $14.8386 per EA under NDC 51167054834. Its NADAC has been published 54 times since Jun 18, 2025.
Strength
50 mg/1
Manufacturer
Vertex Pharmaceuticals IncorporatedNDC
51167054834
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SUZETRIGINEApproval Type
New Drug (NDA)
FDA Application
NDA219209On Market Since
1/30/2025
Pharmacological Classes
Price Statistics
The NADAC for JOURNAVX 50 MG TABLET has been published 54 times since Jun 18, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.8386 per EA |
|---|---|
| All-time high | $14.8567 (Dec 10, 2025) |
| All-time low | $14.8386 (Jun 17, 2026) |
| 52-week high | $14.8567 |
| 52-week low | $14.8386 |
| Median price | $14.8467 |
| Average price | $14.8481 |
| Largest weekly change | -0.1% (Jul 23, 2025) |
| Weeks tracked | 54 |
| Tracking since | Jun 18, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of JOURNAVX 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for JOURNAVX 50 MG TABLET, manufactured by Vertex Pharmaceuticals Incorporated, is $14.8386 per EA (NDC 51167054834), effective Jun 24, 2026.
How has the price of JOURNAVX 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for JOURNAVX 50 MG TABLET has held within roughly two percent of its current level. It has been tracked across 54 weekly CMS publications since Jun 18, 2025.
What are the highest and lowest recorded NADAC prices for JOURNAVX 50 MG TABLET?
Since Jun 18, 2025, the NADAC for JOURNAVX 50 MG TABLET has ranged from a low of $14.8386 (Jun 17, 2026) to a high of $14.8567 (Dec 10, 2025), with a median of $14.8467 per EA.
Are there cheaper alternatives to JOURNAVX 50 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as JOURNAVX 50 MG TABLET, but none are currently priced below it.
Who manufactures JOURNAVX 50 MG TABLET?
JOURNAVX 50 MG TABLET (NDC 51167054834) is labeled by Vertex Pharmaceuticals Incorporated, and CMS classifies it as a brand product.
Related Drugs
Same classification